Paulo Nelson, Mota João, Caseiro Daniel, Gama Vasco
Departmentos de Cirurgia Cardiotorácica e Cardiologia do Centro Hospitalar de Vila Nova de Gaia/ Espinho - Portugal.
Rev Port Cir Cardiotorac Vasc. 2012 Apr-Jun;19(2):75-8.
The use of tanscathether aortic valve implantation (TAVI) to treat severe aortic valve disease is increasing exponentially. Peripheral vascular access for TAVI is not always possible, and when transapical approach is contraindicated, other access options can be considered like the central transaortic access. The authors describe a successful implantation of a CoreValve prosthesis through direct aortic access via ministernotomy, addressing particular attention to the implantation procedure, potencial complications, advantages and limitations of the method.
经导管主动脉瓣植入术（TAVI）用于治疗严重主动脉瓣疾病的应用正在呈指数级增长。TAVI的外周血管入路并非总是可行，当经心尖入路禁忌时，可以考虑其他入路选项，如经主动脉中央入路。作者描述了通过迷你胸骨切开术经主动脉直接入路成功植入CoreValve人工瓣膜的过程，并特别关注植入 procedure、潜在并发症、该方法的优点和局限性。
原文中“procedure”拼写错误，应该是“procedure” ；“potencial”拼写错误，应该是“potential” 。正确译文为：经导管主动脉瓣植入术（TAVI）用于治疗严重主动脉瓣疾病的应用正在呈指数级增长。TAVI的外周血管入路并非总是可行，当经心尖入路禁忌时，可以考虑其他入路选项，如经主动脉中央入路。作者描述了通过迷你胸骨切开术经主动脉直接入路成功植入CoreValve人工瓣膜的过程，并特别关注植入过程、潜在并发症、该方法的优点和局限性。
